SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001583742-23-000001
Filing Date
2023-12-29
Accepted
2023-12-29 14:21:28
Documents
1
Period of Report
2023-12-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4670
  Complete submission text file 0001583742-23-000001.txt   6210
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Issuer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NJ | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ELITE PHARMACEUTICALS, INC. 165 LUDLOW AVE. NORTHVALE NJ 07647
Business Address
Hakim Nasrat A (Reporting) CIK: 0001583742 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15697 | Film No.: 231527066